By uncovering the role of NCL in lung adenocarcinoma, this research will offer fresh perspectives and support for optimizing tumor immune therapy and devising personalized treatment plans, thereby opening up new avenues to enhance patient survival rates and treatment efficacy. The gene discussed is NUCLEOLIN; the disease is neoplasm.